InvestorsHub Logo

AC11

06/12/21 4:58 PM

#30227 RE: fintradingt #30226

Not the same indications. One is plus remdesivir and one is versus placebo. And Chappell sales have been already stated to be pre-scheduled. I think you and Don are reading too much into this.

AC11

06/12/21 5:01 PM

#30228 RE: fintradingt #30226

(Respectfully of course!)

DonDonDonDon

06/12/21 6:21 PM

#30229 RE: fintradingt #30226

Can a double blind trial for a drug take place if the same drug already has an EUA for the same indications?


I think the EUA would end all placebo controlled trials at least in the US. A phase 4 trial would then start after the EUA is granted where there are no placebo patients. Since leronlimab's regular trial didn't have stat sig on mortality maybe they want a more robust ACTIV trial so that stat sig on mortality can be obtained.